Bangalore: The National Aerospace Laboratories Bangalore, a constituent
of the Scientific and Industrial Research (CSIR NAL), has developed a non-invasive
BiPAP Ventilator in a “record 36 days” to treat Covid-19 patients.
‘SwasthVayu’ is a microcontroller-based precise closed-loop
adaptive control system with a built-in biocompatible “3D printed manifold &
coupler” and HEPA filter (Highly Efficient Particulate Air Filter). It has
features like Spontaneous, CPAP, Timed, AUTO BIPAP modes with provision to
connect Oxygen concentrator or Enrichment unit externally.
The system has been certified for safety and performance by
NABL accredited agencies. The system has undergone stringent biomedical tests
and beta clinical trials at NAL Health Centre.
“The non-invasive ventilator will be ideal to treat moderate
or mid-stage severe COVID-19 patients who do not require intubation and
invasive ventilation. This is ideal in treating Covid-19 patients in wards,
make shift hospitals, dispensaries and home in current Indian Covid-19 scenario.
The unique features of the machine also prevent the virus spread,” said
Jitendra J Jadhav, Director, NAL.
The major advantage of the machine is that it is simple to use without any specialized nursing, cost effective, compact and configured with majority of indigenous components. CSIR-NAL is in process of taking it forward with the regulatory authorities for approval, which is expected shortly. The CSIR-NAL has initiated dialogues with major public/private industries for collaboration in mass production of the machine.